New: rebn

jktrades (45)in topgainers • 2 years ago
Top Gainers for 12-12-22: $APVO $HTGM $KWE $REBN
$APVO - 100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$0.00
0

Top Gainers for 12-12-22: $APVO $HTGM $KWE $REBN